Medicure Inc
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary … Read more
Medicure Inc (MCUJF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.030x
Based on the latest financial reports, Medicure Inc (MCUJF) has a cash flow conversion efficiency ratio of -0.030x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-519.00K) by net assets ($17.31 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Medicure Inc - Cash Flow Conversion Efficiency Trend (2000–2024)
This chart illustrates how Medicure Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Medicure Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medicure Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ESKER (EKE.SG)
STU:EKE
|
N/A |
|
Chase Packaging Corp
PINK:WHLT
|
-0.054x |
|
1000MERCIS INH. EO-10
F:2PL
|
N/A |
|
CCH Holdings Ltd Ordinary Shares
NASDAQ:CCHH
|
N/A |
|
Rincon Resources Ltd
AU:RCR
|
0.001x |
|
CHINA FORTUNE HLDG.HD001
F:FTQ0
|
N/A |
|
Linus Digital Finance AG
XETRA:LDF
|
-0.045x |
|
Uni-Fuels Holdings Limited Class A Ordinary Shares
NASDAQ:UFG
|
-0.370x |
Annual Cash Flow Conversion Efficiency for Medicure Inc (2000–2024)
The table below shows the annual cash flow conversion efficiency of Medicure Inc from 2000 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $20.78 Million | $1.38 Million | 0.066x | -36.58% |
| 2023-12-31 | $19.90 Million | $2.08 Million | 0.104x | +20.07% |
| 2022-12-31 | $21.00 Million | $1.83 Million | 0.087x | -59.83% |
| 2021-12-31 | $18.41 Million | $3.99 Million | 0.217x | +285.19% |
| 2020-12-31 | $19.15 Million | $-2.24 Million | -0.117x | +78.47% |
| 2019-12-31 | $26.94 Million | $-14.64 Million | -0.543x | -6219.98% |
| 2018-12-31 | $83.59 Million | $742.27K | 0.009x | -96.73% |
| 2017-12-31 | $80.71 Million | $21.92 Million | 0.272x | +65.07% |
| 2016-12-31 | $38.96 Million | $6.41 Million | 0.165x | +414.14% |
| 2015-12-31 | $4.46 Million | $142.79K | 0.032x | +212.89% |
| 2014-12-31 | $-3.91 Million | $110.88K | -0.028x | -112.38% |
| 2013-12-31 | $-4.33 Million | $-990.48K | 0.229x | +199.88% |
| 2012-12-31 | $-1.82 Million | $417.29K | -0.229x | +72.40% |
| 2011-12-31 | $-574.99K | $477.48K | -0.830x | -1526.51% |
| 2010-12-31 | $-24.96 Million | $-1.45 Million | 0.058x | -87.96% |
| 2009-12-31 | $-21.55 Million | $-10.42 Million | 0.483x | -92.43% |
| 2008-12-31 | $-6.56 Million | $-41.86 Million | 6.386x | +567.29% |
| 2007-12-31 | $18.48 Million | $-25.25 Million | -1.367x | -300.62% |
| 2006-12-31 | $37.17 Million | $-12.68 Million | -0.341x | +79.25% |
| 2005-12-31 | $7.34 Million | $-12.07 Million | -1.644x | -476.36% |
| 2004-12-31 | $21.57 Million | $-6.15 Million | -0.285x | +64.61% |
| 2003-12-31 | $4.94 Million | $-3.98 Million | -0.806x | -73.80% |
| 2002-12-31 | $8.99 Million | $-4.17 Million | -0.464x | 0.00% |
| 2001-12-31 | $8.99 Million | $-4.17 Million | -0.464x | +34.57% |
| 2000-12-31 | $3.85 Million | $-2.73 Million | -0.709x | -- |